Syndrome des antiphospholipides

Syndrome des antiphospholipides

  
Saccone G et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017 Jan 30Lire le résumé
Cochery-Nouvellon É et al. Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. The NOH-ANGIO observational cohort study. Haematologica. 2017 Jan 25Lire le résumé
Abrahams VM et al. The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome. J Hum Genet. 2017 Apr 20Lire le résumé
Mimi Kim et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis published on January 25, 2018Lire le résumé
Rashidi A, Fisher SI. Clinical Images: Lupus erythematosus cell. Arthritis & Rheumatology. 2018 May
14


Nakamura H, Fujieda Y, Yasuda S, Nakai M, Atsumi T. Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus. Ann
Intern Med. 2018 May 1;


Sciascia Sciascia SS, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. Annals of the Rheumatic Diseases. 2018 May 18;
annrheumdis-2018-213496.
Lire le résumé
Pengo V, Denas G, Zoppellaro G, Padayattil Jose S, Hoxha A, Ruffatti A, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018 Jul 12;blood-2018-04-848333.Lire le résumé
Sanchez A, Montaudie H, Bory P, Belgodere X, Passeron T, Lacour JP, et al. Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma. JAMA Dermatology [Internet]. 2018 Sep 19 [cited 2018 Oct 23]; Lire le résumé
Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23
avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901
Lire le résumé
Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The Epidemiology of Antiphospholipid Syndrome. A Population‐Based Study. Arthritis Rheumatol [Internet]. 8 avr 2019 [cité 23
avr 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40901
Lire le résumé
Gris J-C, Mousty È, Bouvier S, Ripart S, Cochery-Nouvellon É, Fabbro-Peray P, et al. Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the the NOH-APS cohort., Haematologica. 17 mai 2019;haematol.2018.213991Lire le résumé
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmun Rev. avr 2019;18(4):406‑14Lire le résumé
Jesús G, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, et al. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome ( APS ) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG Int J Obstet Gynaecol [Internet]. 24 oct 2018 [cité 14 mai 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.15469Lire le résumé